Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer: Untapped clinical utility and PARP inhibitor trial eligibility.

Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer: Untapped clinical utility and PARP inhibitor trial eligibility. Other Scholarly Work

Beitsch, Peter D; Whitworth, Pat W; Hughes, Kevin S; Patel, Rakesh; Baron, Paul; Rosen, Barry; Grady, Ian; Holmes, Dennis; Simmons, Rache M; Smith, Linda Ann; Compagnoni, Gia; Coomer, Cynara L; Brown, Eric Allen; Barbosa, Karen; Clark, Patricia; Gold, Linsey P; Riley, Lee B; Esplin, Edward D; Yang, Shan; Nussbaum, Robert L